Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-132,455
Closed -$3.96M 3525
2025
Q3
$3.96M Sell
132,455
-139,227
-51% -$4.65M 0.01% 1481
2025
Q2
$8.07M Buy
271,682
+2,290
+0.9% +$66K 0.01% 1060
2025
Q1
$8.22M Buy
269,392
+145,127
+117% +$4.89M 0.01% 1025
2024
Q4
$4.92M Buy
+124,265
New +$4.83M 0.01% 1297
2018
Q3
Sell
-5,443
Closed -$300K 2010
2018
Q2
$300K Buy
+5,443
New +$251K ﹤0.01% 1522

Other funds holding SRDX

Dmitry Balyasny's SRDX Position: Q4 2025 in Review

Dmitry Balyasny sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 132,455 shares — an estimated $3.96M sold.

Dmitry Balyasny first reported a position in SRDX in Q2 2018 and held it in 5 quarters. The position peaked at $8.22M in Q1 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Dmitry Balyasny reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Dmitry Balyasny sold 132,455 Surmodics shares in Q4 2025, an estimated $3.96M.
  • Dmitry Balyasny first reported a position in Surmodics in Q2 2018 and held it in 5 quarters.
  • Dmitry Balyasny's Surmodics position peaked at $8.22M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.